• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Serological survey of nasopharyngeal carcinoma in 21 cities of south China.

作者信息

Deng H, Zeng Y, Lei Y, Zhao Z, Wang P, Li B, Pi Z, Tan B, Zheng Y, Pan W

机构信息

Wuzhou Institute for Cancer Research, Guangxi.

出版信息

Chin Med J (Engl). 1995 Apr;108(4):300-3.

PMID:7789220
Abstract

This paper reports the results of serological survey of 318,912 persons for nasopharyngeal carcinoma (NPC) in 21 cities and counties of south China. There were 8,441 persons with positive VCA-IgA antibody (single item positive) of EB virus (EBV), with a rate of 2.65%. In these VCA-IgA positive persons, 287 persons also had positive EA-IgA (double items positive) of EBV. The overall positive rate was 0.09%. 100 cases of NPC were found and 87 of them (87.0%) were in early stage. NPC found in the group with single item positive accounts for 1.19%, but the rate in the group with double items positive was 19.16% (55 cases). In NPC patients with double items positive, 49 cases were in early stage (89.1%). In 100 cases of NPC found, 45 cases appeared with negative EA-IgA, only with positive VCA-IgA, which indicated that for diagnosis of NPC, sensitivity of EA-IgA was lower than that of VCA-IgA, but its specificity was higher. Therefore, both can increase the detecting rate and early diagnosis rate of NPC. The age of people checked varied with different antibody positive rate and NPC detecting rate. The three items showed a positive correlation. The results are compatible with those of the prospective study for NPC in Wuzhou City, Guangxi, China. The method for NPC serological diagnosis can be extended and applied to raise the NPC detecting rate and early diagnosis rate at secondary prevention. And, it is further proved that there is a close relationship between NPC and EBV.

摘要

相似文献

1
Serological survey of nasopharyngeal carcinoma in 21 cities of south China.
Chin Med J (Engl). 1995 Apr;108(4):300-3.
2
Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.广东四会鼻咽癌患者血清免疫球蛋白A抗EB病毒衣壳抗原预处理滴度的预后意义
Ai Zheng. 2009 Jan;28(1):57-9. Epub 2009 Jan 24.
3
Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.鼻咽癌患者血浆中爱泼斯坦-巴尔病毒(EBV)DNA水平与血清EBV免疫球蛋白A/病毒衣壳抗原抗体滴度的比较。
Cancer. 2004 Mar 15;100(6):1162-70. doi: 10.1002/cncr.20099.
4
Epstein-Barr virus seroepidemiology in China.中国的爱泼斯坦-巴尔病毒血清流行病学
AIDS Res. 1986 Dec;2 Suppl 1:S7-15.
5
Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.鼻咽癌中的杂合性缺失及其与临床结局和爱泼斯坦-巴尔病毒感染的相关性。
Anticancer Res. 2001 Jul-Aug;21(4B):3021-9.
6
Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.联合检测爱泼斯坦-巴尔病毒相关抗体和抗原用于鼻咽癌诊断
Ai Zheng. 2009 Jan;28(1):76-8. Epub 2009 Jan 22.
7
Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.爱泼斯坦-巴尔病毒IGA滴度在鼻咽癌诊断中的敏感性和特异性:一项为期三年的机构回顾
Head Neck. 2004 Jul;26(7):598-602. doi: 10.1002/hed.20022.
8
[Serologic screening on nasopharyngeal cancer in 338,868 persons in 21 cities and counties of Guangxi Region, China].[中国广西地区21个市县338868人鼻咽癌血清学筛查]
Zhonghua Yu Fang Yi Xue Za Zhi. 1995 Nov;29(6):342-3.
9
Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.突尼斯两个年龄组中三种不同血清学技术用于鼻咽癌初步诊断和监测的比较
J Med Virol. 2005 Apr;75(4):593-602. doi: 10.1002/jmv.20310.
10
[A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients].[鼻咽癌患者EB病毒VCA/IgA和EA/IgA抗体滴度的动态研究]
Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):243-5.

引用本文的文献

1
A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma.一种用于鼻咽癌晚期诊断的新型血清蛋白生物标志物。
BMC Cancer. 2025 Apr 1;25(1):585. doi: 10.1186/s12885-025-13958-8.
2
Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma.鼻咽癌中 EB 病毒 DNA 及其他液体活检标志物的临床实用性。
Cancer Commun (Lond). 2020 Nov;40(11):564-585. doi: 10.1002/cac2.12100. Epub 2020 Sep 28.
3
Associations between environmental factors and serological Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma in South China.
中国南方地区鼻咽癌患者血清 EB 病毒抗体与环境因素的相关性研究。
Cancer Med. 2019 Aug;8(10):4852-4866. doi: 10.1002/cam4.2348. Epub 2019 Jun 26.
4
Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study.年龄校正的查尔森合并症指数对鼻咽癌放疗后患者临床结局的有效性:一项为期5年的全国队列研究。
PLoS One. 2015 Jan 24;10(1):e0117323. doi: 10.1371/journal.pone.0117323. eCollection 2015.
5
Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China.中国南方鼻咽癌预测风险的基因特征评估与整合
Biomed Res Int. 2014;2014:434072. doi: 10.1155/2014/434072. Epub 2014 Aug 10.
6
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.爱泼斯坦-巴尔病毒感染的血清学诊断:问题与解决方法
World J Virol. 2012 Feb 12;1(1):31-43. doi: 10.5501/wjv.v1.i1.31.
7
Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.中国南方高危人群中鼻咽癌非病毒危险因素的评估。
Int J Cancer. 2009 Jun 15;124(12):2942-7. doi: 10.1002/ijc.24293.
8
Evaluation of a multianalyte profiling assay and an enzyme-linked immunosorbent assay for serological examination of Epstein-Barr virus-specific antibody responses in diagnosis of nasopharyngeal carcinoma.用于鼻咽癌诊断中爱泼斯坦-巴尔病毒特异性抗体反应血清学检测的多分析物检测法和酶联免疫吸附测定法的评估
Clin Vaccine Immunol. 2008 Nov;15(11):1684-8. doi: 10.1128/CVI.00135-08. Epub 2008 Sep 3.
9
Laboratory assays for Epstein-Barr virus-related disease.爱泼斯坦-巴尔病毒相关疾病的实验室检测
J Mol Diagn. 2008 Jul;10(4):279-92. doi: 10.2353/jmoldx.2008.080023. Epub 2008 Jun 13.
10
Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility.中国东南部导致慢性EB病毒感染和鼻咽癌的遗传因素:研究设计、方法与可行性
Hum Genomics. 2006 Jun;2(6):365-75. doi: 10.1186/1479-7364-2-6-365.